Day One Biopharmaceuticals

IPO

Targeted Therapies for Children and Adults

Public · Brisbane, United States · Founded 2018 · $190.0M raised

Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$190.0M
Last Round
$130.0M Series BFeb 2021
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Day One Biopharmaceuticals is a commercial-stage oncology company focused on developing and commercializing targeted therapies for patients with cancer, beginning with pediatric cancers. The company's lead product, tovorafenib (OJEMDA), is the first FDA-approved therapy for pediatric low-grade glioma (pLGG) and is being explored in additional tumor types driven by BRAF alterations.

Summary

Day One Biopharmaceuticals is a Biotech company based in Brisbane, United States, founded in 2018. It has raised $190.0M in total across 2 rounds, most recently a $130.0M Series B round in Feb 2021. Investors include RA Capital Management, Canaan Partners and Fairmount Funds.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Secondary MarketSecondary Market2024 (est.)

Sign up to see all 4 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Day One Biopharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/day-one-biopharmaceuticals"><img src="https://indexed.vc/api/badge/company/day-one-biopharmaceuticals" alt="Day One Biopharmaceuticals on Indexed.vc" width="260" height="76" /></a>